clinical trial · NCT04294472
A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients
BK Virus InfectionMAU868Placebo
brief summary
This clinical research study will test the safety and efficacy of the investigational medication MAU868, compared to a placebo, in patients who have had a kidney transplant who have active BK virus.
started
Aug 5, 2020
primary completion
Feb 10, 2022
completion
Feb 10, 2022
last updated
Jun 7, 2023
official title
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics and Efficacy of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients (Neutra4)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol